12 transactions in one company, from January 2, 2026 to July 16, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | GLUE | 12 | — | $951K |
12 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jul 16 | S | 9,500 | $23.18 | $220K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jun 1 | SPLAN | 468 | $19.73 | $9K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jun 1 | SPLAN | 4,998 | $19.41 | $97K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | May 1 | SPLAN | 5,467 | $18.92 | $103K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Apr 14 | S | 8,000 | $17.64 | $141K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Mar 2 | SPLAN | 5,466 | $17.92 | $98K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jan 7 | SPLAN | 309 | $24.57 | $8K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jan 7 | SPLAN | 1,450 | $23.88 | $35K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jan 7 | SPLAN | 3,707 | $23.24 | $86K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEODERIV | Jan 2 | A | 406,000 | $0.00 | —? |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jan 5 | S | 10,135 | $15.17 | $154K |
| Monte Rosa Therapeutics, Inc. | GLUE | Markus WarmuthCEO | Jan 2 | A | 90,000 | — | — |